ECS_WP_List - 6η Υ.ΠΕ

Work Packages

View: Cards

WP 1

Coordination

LU, Latvia

Tasks

Administrative coordination

Scientific coordination

Steering committee (SC)

Regular reporting

WP 2

Dissemination

DYPEDE, Greece

Tasks

Dissemination strategy and communication action plan

Stakeholders mapping

Project identity

Implementation of communication and dissemination strategy

Dissemination monitoring

WP 3

Evaluation of the project

UWK, Austria

Tasks

Evaluation plan (EP) and logical model (LM)

Evaluation tools (ETs)

Interim and final evaluation

Report of evaluation results to relevant stakeholders

Publication of the results

WP 4

Sustainability

OIL, Slovenia,

co-led by DoH, Ireland

Tasks

Situational analysis regarding the sustainability of screening in participating countries

Development of context specific governance models for cancer screening in Europe

Review of existing methodologies and tools for barrier assessment and linking them together in a meaningful way

Development of methodology for prioritisation in cancer screening/prevention

Establishment of a sustainable European cancer screening network and engagement of Governmental Advisory Board (GAB)

Cancer screening sustainability workshops

WP 5

Monitoring

CSF, Finland

Tasks

Ethical, Legal and Social
Implications (ELSI) assessment of
data sharing

Assessment of data availability and exchange-related issues focusing also on new and riskbased
screening programs

Extended pilot of data entry to the ECIS platform on breast, cervical, and colorectal cancers

Implementing data collection with open-source software and standardised data model for screening to produce key quality and performance indicators

Piloting developed standardised data model for European Health Data Space (EHDS)

WP 6

Addressing barriers and facilitators in cancer screening

OUS, Norway

Tasks

Barrier and facilitator assessment and management in cancer screening programmes across Europe with the emphasis on barriers for successful screening implementation in Eastern and Central Europe

Systemic barriers

Individual barriers

Immigrant populations

Improved cancer screening for people with intellectual
disabilities (IDs)

Outreach strategies to other vulnerable populations, including transgender populations

Strategies to increase health literacy in cancer screening

Information intervention and toolkit of best practice communication resources

WP 7

Implementation research to improve the existing screening programmes

ICO, Spain

Tasks

Implementing quality assurance (QA) scheme

Classification and reporting of interval cancer rates

Integration of artificial intelligence in cancer screening programmes

Innovative approaches to invite target population in cancer screening programmes

Implementing informed decision-making in population-based cancer screening programmes

WP 8

Facilitation of the new screening approach implementation

NKIP, Hungary,

co-led by SCI, Belgium

Tasks

Support to methodology and harmonisation of data sets for lung cancer screening pilots

Support to methodology and harmonisation of data sets of gastric cancer prevention

Support to methodology and harmonisation of data sets of prostate cancer screening

Feasibility of H.pylori stool antigen testing (SAT) in combination with FIT-based colorectal cancer screening programs

Integrating intensive smoking cessation with low-dose CTscreening
among heavy smokers

WP 9

Risk-based approaches

ISPRO, Italy,

co-led by UNICANCER, France

Tasks

Development and assessment of methods for promoting informed choice and communication in personalised programs

Innovative approaches to risk stratification and available tools

Individualised cervical cancer screening, including integrating state-of the-art triage methods to screening

Risk-based colorectal cancer screening

Breast cancer screening based on individual risk characteristics

Integrating primary, secondary and tertiary prevention with screening

The role of risk stratification in new screenings (lung, prostate, gastric)

WP 10

Modelling and health technology assessment to optimise cancer screening programs across Europe

EMC, Netherlands

Tasks

Adapting cervical cancer screening programmes to HPV
vaccinated birth cohorts

Estimation of benefits, harms, and resource requirements of current screening programs and the impact of addressing barriers and facilitators or enablers

Estimation of benefits, harms, and resource requirements to implement new screening approaches

Comparison of benefits, harms, and resource requirements across screening programs to help countries prioritise screening interventions

Assessment of new technologies and approaches in cancer screening

Estimation of benefits, harms, and resource requirements of riskbased screening approaches

Medico-economical modelling and cost effectiveness of multicancer early detection (MCED) tests

WP 11

Capacity-building

IOCN, Romania,

co-led by SPKC, Latvia

Tasks

Leadership training in cancer screening

Education and certification of physicians on new screening approaches

Training and audit of colonoscopies

Training and audit of upper endoscopies

Cervical cancer screening specialist training and regional training centre

Training and audit of the quality of low-dose CT (LDCT) scans: a regional (LDCT) training centre

Regional mammography training centre

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959